Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults
Author(s) -
Boris Tchakounte Youngui,
Patrick Coffié,
Eugène Messou,
Armel Poda,
L. Fortes Déguévo,
Denise Hawerlander,
Albert Minga,
Éric Balestre,
François Dabis,
Olivier Marcy
Publication year - 2020
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofaa203
Subject(s) - medicine , incidence (geometry) , tuberculosis , poisson regression , antiretroviral treatment , antiretroviral therapy , human immunodeficiency virus (hiv) , body mass index , isoniazid , coinfection , pediatrics , demography , immunology , viral load , environmental health , population , pathology , optics , physics , sociology
We estimated tuberculosis incidence during the first year on antriretroviral therapy without isoniazid-preventive treatment in 6938 West African HIV-infected adults at 3.33 cases per 100 person-years (95% CI, 2.85–3.80). In multivariate Poisson models, sites in Cote d’Ivoire, male gender, low body mass index, low hemoglobin, low CD4 count, and young age were significantly associated with higher incidence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom